Calendario de promoción Sonnet BioTherapeutics Holdings, Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer and is under phase 1 trial. más detalles| IPO date | 2006-10-31 |
|---|---|
| ISIN | US83548R2040 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.sonnetbio.com |
| Цена ао | 1.33 |
| Cambio de precio por día: | 0% (1.31) |
|---|---|
| Cambio de precio por semana.: | -5.07% (1.38) |
| Cambio de precio por mes: | -13.82% (1.52) |
| Cambio de precio en 3 meses.: | -13.25% (1.51) |
| Cambio de precio en seis meses: | -80.42% (6.69) |
| Cambio de precio por año: | -29.57% (1.86) |
| Cambio de precio en 3 años.: | +220.29% (0.409) |
| Cambio de precio en 5 años.: | +236.07% (0.3898) |
| Cambio de precio desde principios de año.: | -10.27% (1.46) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| Renaissance Technologies, LLC | 43749 | 1.43 |
| Citadel Advisors Llc | 29447 | 0.96 |
| Vanguard Group Inc | 14726 | 0.48 |
| Tower Research Capital LLC (TRC) | 2094 | 0.07 |
| Blackrock Inc. | 594 | 0.02 |
| Morgan Stanley | 61 | 0 |
| Osaic Holdings Inc | 45 | 0 |
| Wells Fargo & Company | 21 | 0 |
| JP Morgan Chase & Company | 19 | 0 |
| Private Wealth Management Group, LLC | 3 | 0 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Dr. Pankaj Mohan Ph.D. | Founder, Chairman, CEO & President | 927k | 1965 (60 años) |
| Dr. John K. Cini Ph.D. | Chief Scientific Officer & Co-Founder | 602.48k | 1953 (72 año) |
| Mr. Jay Cross | Chief Financial Officer | 603.42k | 1971 (54 año) |
| Mr. Donald J. Griffith CPA, CPA | Controller & Director | 134.05k | 1949 (76 años) |
| Ms. Susan Dexter | Chief Technical Officer | N/A | 1955 (70 años) |
| Dr. Richard T. Kenney FACP, M.D. | Chief Medical Officer | N/A | 1958 (67 años) |
| Mr. Manuel Dafonseca | Head of Clinical Operations | N/A |
DIRECCIÓN: United States, Princeton. NJ, 100 Overlook Center - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.sonnetbio.com
Sitio web: https://www.sonnetbio.com
